Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Pharm is a vertically integrated international pharmaceutical company headquartered in Russia, with a significant presence in manufacturing, R&D, and commercialization across the CIS, Europe, and the Middle East. The company focuses on high-tech medicines for oncology, hematology, immunology, and infectious diseases, including a robust portfolio of biosimilars and innovative small molecules. R-Pharm gained international prominence for its development of Artlegia (olokizumab) for rheumatoid arthritis and its role in manufacturing the Sputnik V COVID-19 vaccine. Through its international arm, R-Pharm International, the group operates a major manufacturing facility in Illertissen, Germany, providing CDMO services to global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R-Pharm International.